Product Details
Sermorelin is a synthetic peptide analog of a naturally occurring portion of growth hormone–releasing hormone (GHRH). In research settings, it is studied primarily for its interaction with the hypothalamic-pituitary growth hormone axis and its ability to stimulate the pituitary gland’s natural production and release of growth hormone (GH). Unlike compounds that supply growth hormone directly, Sermorelin acts upstream by binding to GHRH receptors on pituitary cells. This signaling can stimulate the release of endogenous growth hormone while remaining subject to the body’s physiological regulatory mechanisms. Growth hormone subsequently influences the production of insulin-like growth factor 1 (IGF-1), an important mediator involved in numerous growth, metabolic, and tissue-related processes. Areas of Research Interest Sermorelin has been investigated in connection with: * Growth hormone secretion and signaling — Research examines its ability to stimulate endogenous GH release and influence GH/IGF-1 pathways. * Age-related changes in the GH axis — GH secretion naturally changes with age, making GHRH analogs an area of interest in endocrine and aging research. * Body composition and metabolism — Growth hormone signaling is involved in lipid metabolism, energy utilization, and the maintenance of lean tissue. * Recovery and tissue physiology — Researchers study GH and IGF-1 signaling because of their roles in cellular growth, repair, and tissue maintenance. * Sleep and circadian physiology — Natural growth hormone secretion occurs in pulses and is closely associated with sleep, particularly deeper stages of sleep. * Exercise and musculoskeletal research — The GH/IGF-1 pathway is studied for its relationship with muscle, connective tissue, and bone physiology. Sermorelin vs. Direct Growth Hormone An important distinction is that Sermorelin does not contain growth hormone. Instead, it is a GHRH analog designed to stimulate signaling that can cause the pituitary gland to release the body’s own growth hormone. This mechanism makes Sermorelin useful in research examining endogenous GH secretion and regulation rather than direct administration of exogenous GH. Research Classification Sermorelin has a history of medical use, but the original FDA-approved Sermorelin product Geref® was discontinued, and Sermorelin is not currently an FDA-approved drug product marketed in the United States. Products sold specifically as research peptides should therefore not be represented as approved treatments or as proven to diagnose, treat, cure, or prevent disease. For research and educational purposes only. Not intended for human consumption or for the diagnosis, treatment, cure, or prevention of any disease.